The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
SHARE
US

Planned Parenthood Should Face Medicaid Fraud Lawsuit, Rules Judge

The organization billed Texas and Louisiana under Medicaid programs despite being disqualified.
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Save
Planned Parenthood Should Face Medicaid Fraud Lawsuit, Rules Judge
A Planned Parenthood facility in Anaheim, Calif., on Sept. 10, 2020. John Fredricks/The Epoch Times
Naveen Athrappully
By Naveen Athrappully
10/24/2023Updated: 10/24/2023

Planned Parenthood will have to face a trial that could force it to shell out up to $1.8 billion as part of a lawsuit accusing the organization of overbilling Medicare programs in two states, according to a recent district court ruling.

The lawsuit concerns “thousands” of Medicare claims that Planned Parenthood billed to the states of Texas and Louisiana even after the states terminated the organization as a provider under its Medicare insurance programs. Both Planned Parenthood and Texas asked the judge to rule in their favor. However, U.S. District Judge Matthew Kacsmaryk declined to do so. On Monday, he scheduled a trial set to start in April. 16, 2024.
Naveen Athrappully
Naveen Athrappully
Author
Naveen Athrappully is a news reporter covering business and world events at The Epoch Times.
Author’s Selected Articles

Fed’s Beige Book Reports Lower Economic Activity, ‘Slightly Pessimistic’ Outlook

Jun 05, 2025
Fed’s Beige Book Reports Lower Economic Activity, ‘Slightly Pessimistic’ Outlook

Price Gap Narrows Between Existing and New US Homes

Jun 04, 2025
Price Gap Narrows Between Existing and New US Homes

Texas Removes BlackRock From Investment Blacklist

Jun 04, 2025
Texas Removes BlackRock From Investment Blacklist

Optimism for American Agriculture Highest in 4 Years: Farmer Survey

Jun 04, 2025
Optimism for American Agriculture Highest in 4 Years: Farmer Survey
Related Topics
Medicare fees
Planned Parenthood
Save
The Epoch Times
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.